AI Assistant
Blog
Pricing
Log In
Sign Up
P487 Early vedolizumab trough levels are not associated with a short-term response in patients with inflammatory bowel disease
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
